Pharmaceutical Company Collaborates with Patient Organizations to Incorporate Patient Feedback into Company-Wide Research and Development Efforts
Source
VOZ Advisors
Description of Case Study
Incyte Corporation, a global pharmaceutical company, sought to develop a consistent, sustainable path to incorporating patient input into clinical development. In late 2021, two internal champions in clinical operations launched a one-year pilot patient council, partnering with consulting firm VOZ Advisors and recruiting patient/care partner experts across hematology, oncology, myeloproliferative neoplasms, and dermatology/autoimmunity, with attention to racial, ethnic, geographic, age, and gender diversity. Over seven engagements, the council reviewed study protocols and informed consent forms (ICFs), a plain-language summary, a dermatology study dosing diary, and preferred methods for learning about clinical trials. Based on pilot results, Incyte expanded the council to include lay patients and additional therapeutic areas, formalized a patient engagement playbook, created a centralized repository of patient insights, and routed all patient/advocacy-organization outreach through a single public affairs contact. By 2025, the council had grown its engagement activity substantially, and Incyte instituted a company-wide requirement that all studies either directly engage the patient council or incorporate relevant insights from the repository.
Quick Facts Organization name: Incyte Corporation |
Product Type(s)
- pharmaceutical/biological product
Product Medical Specialty Area(s)
- hematology
- immunology
- other (oncology, dermatology)
Stakeholders
- pharmaceutical company: internal discovery/research and development (R&D) teams
- pharmaceutical company: internal clinical affairs/R&D teams
- pharmaceutical company: internal medical affairs teams
- patients and caregivers, patient organizations
- other: consulting firm
Methods and Sources of Patient Input
- patient advisory boards
- patient advocacy organizations
- interviews/focus groups/surveys
- patient-sensitive design controls
Impact of Patient Engagement
- Direct improvements to study materials and processes: Initially, the one-year pilot of the patient council produced study protocol and ICF updates, plain-language summary improvements, dosing diary updates, clinical trial website recommendations, and input on the use of Google Ads for trial awareness.
- Development of a patient engagement playbook: The success of the pilot effort led to company-wide adoption of patient engagement processes and the development of a company patient engagement playbook.
- Company-wide adoption of patient engagement: Recognition of the patient council’s value led the company to require that all studies either engage the patient council or otherwise incorporate patient input.
- Cross-functional accessibility of patient insights: Additionally, patient insights from across the organization became accessible via a repository for cross-functional teams to reference.
- Cultural and organizational shift: Ultimately, a pilot initiative transformed into a structured approach to incorporate patient feedback into the development of all future products.
Lessons Learned
- A single awareness event does not drive uptake; proactive outreach does: A one-time “Lunch and Learn” to promote the playbook and council was insufficient to spark organization-wide uptake. Engagement increased substantially only after the team proactively identified studies approaching critical milestones (e.g., protocol submission) and contacted study teams directly.
- Direct exposure builds buy-in: Team members who observed council meetings shifted from viewing patient engagement as a “nice to have” to seeing it as critical to study success, becoming internal champions.
- A single point of contact prevents the overburdening of patient groups: Routing recruitment outreach through one public affairs contact avoided duplicate or competing requests to patient organizations and supported recruitment of underrepresented communities.
- A shared insights repository avoids redundant requests and demonstrates value: Centralizing and categorizing council feedback by topic let teams review prior insights before requesting new input and helped identify the types of feedback most often needed.
- Closing the feedback loop sustains participation: Reporting back to the council after each engagement on how (or whether) their input was applied helped build trust and maintain high participation over time.
- Leadership buy-in follows demonstrated value: Tying patient engagement to organizational goals and leadership’s direct observation of improvements to study materials was central to securing the resources and mandate for company-wide expansion.